(NYSE: ELV) Elevance Health's forecast annual revenue growth rate of 4.42% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 5.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.75%.
Elevance Health's revenue in 2024 is $171,745,000,000.On average, 15 Wall Street analysts forecast ELV's revenue for 2024 to be $40,017,215,381,764, with the lowest ELV revenue forecast at $39,728,115,677,778, and the highest ELV revenue forecast at $40,622,064,519,620. On average, 14 Wall Street analysts forecast ELV's revenue for 2025 to be $42,487,406,625,603, with the lowest ELV revenue forecast at $41,501,487,244,775, and the highest ELV revenue forecast at $43,680,358,264,326.
In 2026, ELV is forecast to generate $45,605,356,458,739 in revenue, with the lowest revenue forecast at $44,270,374,261,493 and the highest revenue forecast at $48,176,040,307,494.